Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC10277501/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC10277501/. The analysis below is for the second page.

Title[redir]:
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases - PMC
Description:
During the past decade, there has been a revolution in cancer therapeutics by the emergence of antibody-based immunotherapies that modulate immune responses against tumors. These therapies have offered treatment options to patients who are no longer ...

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Science
  • Education

Content Management System {πŸ“}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {πŸ’Έ}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.

Keywords {πŸ”}

doi, pubmed, google, scholar, patients, pmc, iraes, article, free, cells, immune, cancer, ctla, ici, checkpoint, mice, autoimmune, cell, preexisting, immunotherapy, adverse, inhibitors, treatment, events, melanoma, disease, increased, activation, development, therapy, immunerelated, study, developed, oncol, blockade, treated, antipd, showed, clin, studies, tumor, clinical, icis, survival, pdl, response, association, diseases, role, immunol,

Topics {βœ’οΈ}

c57bl/6lpr/lpr-pd-1-/- mice resembled t-bet+rorΞ³t+ th17/1 effectors c57bl/6-lpr/lpr-pd-1-/- mice compared resembled graft-versus-host disease complement-dependent antibody-mediated cytotoxicity balb/c-rag-2-/-pd-1-/- mice pd-1/pd-l1 blocking compounds dress/drug-induced hypersensitivity syndrome releasing free pd-l1 ctla-4f/fcd19cre/+ mice led anti-cytotoxic t-lymphocyte antigen-4 nih/nci grants ca238263 c57bl/6lpr/lpr mice prolonged progression-free survival pd-1/pd-l1 blockade induces pmc beta search itim motif-carrying immunoreceptor inhibitory pathway pd-1/pd-l1 immune-related adverse events progression-free survival compared single-cell immune landscape mrl-faslpr/lpr mouse pre-existing auto-antibodies increased progression-free survival treatment-related adverse events immune-related adverse effects t-cell checkpoint blockade potential flair-ups due anti-thyroid peroxidase antibodies pre-treatment faucal abundance cardiovascular-related adverse effects real-world transverse study foxp3-expressing treg cells cross-sectional study showed cell-driven plaque inflammation c57bl/6lpr/lpr including stevens-johnson syndrome host cell pd-l1 pre-existing autoimmune disorders mab-treated mice displayed tumor necrosis factor-alpha pd-1 receptor-deficient mice positive anti-nuclear antibody peripheral t-cell tolerance pre-existing autoimmune diseases matched case-control study adjuvant anti-pd-1 therapy anti-programmed death-1 immunotherapy c57bl/6/pd-1-/- mice showed steroid-sparing biologic immunosuppressants

Social Networks {πŸ‘}(6)

External Links {πŸ”—}(347)

Analytics and Tracking {πŸ“Š}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {πŸ“š}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {πŸ“¦}

  • Ncbi

4.62s.